Ronald Fernando
Internal Medicine · Loma Linda, CANPI 1447355565
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,473 of the $2,062 with a category attached, or 71.4%. Novo Nordisk AS accounts for 83.4% of it on its own, with 2 other manufacturers making up the rest.
Across 11 payments — averaging $187.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$2K
- Amgen$245
- Novo Nordisk$97
Across 1,011 payments — averaging $974.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$338K
- Bayer$267K
- AstraZeneca$109K
- Kowa Research Institute, Inc.$106K
- Amgen$99K
- AbbVie$67K
What the payments were for
- Travel & lodging$1,47371%
- Food & beverage$49224%
- Education$975%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 4 | $1,721 |
| Amgen | 4 | $245 |
| Novo Nordisk | 3 | $97 |
How this compares
$2,062 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Loma Linda
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.